JPH04316497A - Analytical element and its production - Google Patents
Analytical element and its productionInfo
- Publication number
- JPH04316497A JPH04316497A JP8272891A JP8272891A JPH04316497A JP H04316497 A JPH04316497 A JP H04316497A JP 8272891 A JP8272891 A JP 8272891A JP 8272891 A JP8272891 A JP 8272891A JP H04316497 A JPH04316497 A JP H04316497A
- Authority
- JP
- Japan
- Prior art keywords
- analytical element
- reagent layer
- layer
- coupler
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 40
- 102000004190 Enzymes Human genes 0.000 claims abstract description 23
- 108090000790 Enzymes Proteins 0.000 claims abstract description 23
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 9
- 239000007787 solid Substances 0.000 claims abstract description 7
- 239000013060 biological fluid Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 13
- 239000000126 substance Substances 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 64
- 108010077078 Creatinase Proteins 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 108010060059 Sarcosine Oxidase Proteins 0.000 description 16
- 102000008118 Sarcosine oxidase Human genes 0.000 description 16
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 12
- 239000011248 coating agent Substances 0.000 description 11
- 238000000576 coating method Methods 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 229940098773 bovine serum albumin Drugs 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 8
- 108010066906 Creatininase Proteins 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical group [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 6
- 229940109239 creatinine Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- -1 p -nonylphenoxy Chemical group 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 5
- 102000003992 Peroxidases Human genes 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 239000006174 pH buffer Substances 0.000 description 5
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 5
- 238000003892 spreading Methods 0.000 description 5
- 230000007480 spreading Effects 0.000 description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 4
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000012790 adhesive layer Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007998 bicine buffer Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 229960003624 creatine Drugs 0.000 description 3
- 239000006046 creatine Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- ZKGIQGUWLGYKMA-UHFFFAOYSA-N 1,2-bis(ethenylsulfonyl)ethane Chemical group C=CS(=O)(=O)CCS(=O)(=O)C=C ZKGIQGUWLGYKMA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 108700020962 Peroxidase Proteins 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000012494 forced degradation Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001846 repelling effect Effects 0.000 description 2
- NHQVTOYJPBRYNG-UHFFFAOYSA-M sodium;2,4,7-tri(propan-2-yl)naphthalene-1-sulfonate Chemical group [Na+].CC(C)C1=CC(C(C)C)=C(S([O-])(=O)=O)C2=CC(C(C)C)=CC=C21 NHQVTOYJPBRYNG-UHFFFAOYSA-M 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 238000001132 ultrasonic dispersion Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- JHDXAQHGAJXNBY-UHFFFAOYSA-M 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonate;tetraethylazanium Chemical compound CC[N+](CC)(CC)CC.[O-]S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F JHDXAQHGAJXNBY-UHFFFAOYSA-M 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 102100024482 Cell division cycle-associated protein 4 Human genes 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 1
- 239000007996 HEPPS buffer Substances 0.000 description 1
- 101100383112 Homo sapiens CDCA4 gene Proteins 0.000 description 1
- YNLCVAQJIKOXER-UHFFFAOYSA-N N-[tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid Chemical compound OCC(CO)(CO)NCCCS(O)(=O)=O YNLCVAQJIKOXER-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- BADXJIPKFRBFOT-UHFFFAOYSA-N dimedone Chemical compound CC1(C)CC(=O)CC(=O)C1 BADXJIPKFRBFOT-UHFFFAOYSA-N 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007765 extrusion coating Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
- KQDIGHIVUUADBZ-PEDHHIEDSA-N pentigetide Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O KQDIGHIVUUADBZ-PEDHHIEDSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920002557 polyglycidol polymer Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- KWURIFKZTJGMFD-UHFFFAOYSA-M potassium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate Chemical compound [K+].OCCN1CCN(CCS([O-])(=O)=O)CC1 KWURIFKZTJGMFD-UHFFFAOYSA-M 0.000 description 1
- BUCIWTBCUUHRHZ-UHFFFAOYSA-K potassium;disodium;dihydrogen phosphate;hydrogen phosphate Chemical compound [Na+].[Na+].[K+].OP(O)([O-])=O.OP([O-])([O-])=O BUCIWTBCUUHRHZ-UHFFFAOYSA-K 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- GUXMFAHOYNRHBI-UHFFFAOYSA-M sodium;2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]ethanesulfonate Chemical compound [Na+].OCC(CO)(CO)NCCS([O-])(=O)=O GUXMFAHOYNRHBI-UHFFFAOYSA-M 0.000 description 1
- FEGYIWVHCSRXCG-UHFFFAOYSA-M sodium;3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]propane-1-sulfonate Chemical compound [Na+].OCC(CO)(CO)NCCCS([O-])(=O)=O FEGYIWVHCSRXCG-UHFFFAOYSA-M 0.000 description 1
- FYKDNWHPKQOZOT-UHFFFAOYSA-M sodium;dihydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].OP(O)([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FYKDNWHPKQOZOT-UHFFFAOYSA-M 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、例えばザルコシンオキ
シダーゼ等の酵素を含有させた分析素子に関するもので
ある。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an analytical element containing an enzyme such as sarcosine oxidase.
【0002】0002
【発明の背景】例えば、特開昭64−98952号公報
に記載されているクレアチニナーゼ、クレアチナーゼ、
ザルコシンオキシダーゼ、ペルオキシダーゼ等の酵素を
用いてクレアチニンを測定する分析素子は、これらの酵
素を水に溶解させた後、ゼラチン溶液に添加したり、あ
るいは酵素を直接ゼラチン溶液に添加し、このようにし
て得られた酵素含有試薬層溶液を支持体上に塗布するこ
とで製造されている。BACKGROUND OF THE INVENTION For example, creatininase, creatinase, and
Analytical elements that measure creatinine using enzymes such as sarcosine oxidase and peroxidase can be prepared by dissolving these enzymes in water and then adding them to the gelatin solution, or by directly adding the enzymes to the gelatin solution. It is manufactured by coating the enzyme-containing reagent layer solution obtained by the following steps on a support.
【0003】しかしながら、このようにして得られた分
析素子は、性能にバラツキが大きい問題点が有る。特に
、前記酵素が含有される試薬層溶液中に、例えば7−ク
ロロ−3−(2−ヘキシルデシルスルホニルエチル)−
6−メチル−ピラゾロ−〔3,2−c〕−s−トリアゾ
ール等のカプラーをオイルプロテクト法を用いて分散含
有させた場合にあっては、感度が著しく低下し、同時再
現性が良くない問題点が有る。[0003] However, the analytical elements obtained in this manner have the problem of large variations in performance. In particular, in the reagent layer solution containing the enzyme, for example, 7-chloro-3-(2-hexyldecylsulfonylethyl)-
When a coupler such as 6-methyl-pyrazolo-[3,2-c]-s-triazole is dispersed and contained using the oil protection method, there is a problem that the sensitivity decreases significantly and the simultaneous reproducibility is poor. There is a point.
【0004】又、このようなカプラー含有試薬溶液の塗
布に際して、はじき等の塗布故障が起きやすく、塗膜の
厚みにバラツキが大きい等の問題点も有る。[0004] Furthermore, when coating such a coupler-containing reagent solution, there are other problems such as coating failures such as repelling and the like, and large variations in the thickness of the coating film.
【0005】[0005]
【発明の開示】本発明の目的は、同時再現性が高く、か
つ、保存性が良い分析素子を提供することである。この
本発明の目的は、支持体上に、例えばオイルプロテクト
法で分散されたカプラー及び酵素を含有する試薬層を有
する生物学的流体試料中の特定成分を分析する為の分析
素子であって、前記試薬層に該試薬層固形分の約10重
量%以上のタンパク質を含有させたことを特徴とする分
析素子によって達成される。DISCLOSURE OF THE INVENTION An object of the present invention is to provide an analytical element with high simultaneous reproducibility and good storage stability. The object of the present invention is an analytical element for analyzing a specific component in a biological fluid sample, which has a reagent layer containing a coupler and an enzyme dispersed, for example, by an oil protection method, on a support. This is achieved by an analytical element characterized in that the reagent layer contains protein in an amount of about 10% by weight or more based on the solid content of the reagent layer.
【0006】又、支持体上に、例えばオイルプロテクト
法で分散されたカプラー及び酵素を含有する試薬層を有
する生物学的流体試料中の特定成分を分析する為の分析
素子の製造方法であって、該試薬層固形分の約10重量
%以上となるように配合されたタンパク質含有溶液中に
前記酵素が添加されて作成された前記オイルプロテクト
法で分散されたカプラー、酵素及びタンパク質含有溶液
が前記支持体上に塗布されることを特徴とする分析素子
の製造方法によって達成される。[0006] Also, a method for producing an analytical element for analyzing a specific component in a biological fluid sample, which has a reagent layer containing a coupler and an enzyme dispersed by, for example, an oil protection method on a support. , the coupler, enzyme and protein-containing solution dispersed by the oil protection method prepared by adding the enzyme to a protein-containing solution blended so that the solid content of the reagent layer is about 10% by weight or more; This is achieved by a method for manufacturing an analytical element, which is characterized in that the analytical element is coated on a support.
【0007】尚、上記の分析素子が生物学的流体試料中
のクレアチン及び/又はクレアチニンを分析する為の分
析素子である場合にあっては、クレアチナーゼが少なく
とも一つの試薬層と展開層とに含有され、そしてザルコ
シンオキシダーゼが試薬層に含有されることが好ましく
、又、クレアチニン分析素子の場合には、さらにクレア
チニナーゼを少なくとも一つの試薬層に含有することが
好ましい。このクレアチナーゼの含有量は試薬層よりも
展開層において多いことが、特に試薬層におけるクレア
チナーゼの含有量と展開層におけるクレアチナーゼの含
有量との比が1対10〜100であることが好ましい。
又、クレアチナーゼの含有量は25000〜20000
0I.U./m2 であることが好ましく、クレアチニ
ナーゼの含有量はクレアチナーゼの含有量に対して1/
2000〜1/15であることが好ましい。[0007] When the above analytical element is an analytical element for analyzing creatine and/or creatinine in a biological fluid sample, creatinase is contained in at least one reagent layer and the developing layer. It is preferable that sarcosine oxidase is contained in the reagent layer, and in the case of a creatinine analysis element, it is preferable that creatininase is further contained in at least one reagent layer. It is preferable that the content of creatinase is higher in the developing layer than in the reagent layer, and in particular, the ratio of the content of creatinase in the reagent layer to the content of creatinase in the developing layer is 1:10 to 100. In addition, the content of creatinase is 25,000 to 20,000
0I. U. /m2, and the creatininase content is 1/m2 relative to the creatinase content.
It is preferable that it is 2000 to 1/15.
【0008】本発明がクレアチン及び/又はクレアチニ
ン測定用の分析素子に応用された場合について説明する
と、次の通りである。クレアチン及び/又はクレアチニ
ンの分析は、下記の一連の反応(1)ないし(4)によ
って行われる。A case where the present invention is applied to an analytical element for measuring creatine and/or creatinine will be explained as follows. Analysis of creatine and/or creatinine is performed by the following series of reactions (1) to (4).
【0009】[0009]
【化1】[Chemical formula 1]
【0010】これらの反応は、クレアチニナーゼ、クレ
アチナーゼ、ザルコシンオキシダーゼ及び過酸化性物質
によってそれぞれ触媒される。クレアチニナーゼ及びク
レアチナーゼは、多数の供給源から市場で得られる。種
々の微生物資源から単離された各酵素の若干の種類が文
献に知られている。37℃で6.5の至適pHを有する
クレアチニナーゼ及び37℃で7.7の至適pHを有す
るクレアチナーゼ(両者共にフラボバクテリウムの菌株
から得られる)が好ましい。These reactions are catalyzed by creatininase, creatinase, sarcosine oxidase and peroxidizing substances, respectively. Creatinase and creatinase are commercially available from a number of sources. Several types of each enzyme isolated from various microbial sources are known in the literature. Creatininase with a pH optimum of 6.5 at 37°C and creatinase with a pH optimum of 7.7 at 37°C, both obtained from strains of Flavobacterium, are preferred.
【0011】ザルコシンオキシダーゼも多数の供給源か
ら得られる。例えば、特開昭55−34001号公報、
特開昭56−92790号公報、特開昭61−1621
74号公報に記載されている。過酸化性物質はペルオキ
シダーゼを含む。本発明に有用なペルオキシダーゼは植
物又は微生物由来のものである。Sarcosine oxidase is also obtained from a number of sources. For example, Japanese Patent Application Laid-Open No. 55-34001,
JP-A-56-92790, JP-A-61-1621
It is described in Publication No. 74. Peroxidizing substances include peroxidases. Peroxidases useful in the present invention are of plant or microbial origin.
【0012】本発明に用いられる色素前駆体としてのカ
プラーは、特開昭57−94653号公報、特開昭57
−94654号公報、特開昭57−94655号公報、
特開昭60−47696号公報、特開昭63−1271
58号公報、特開昭63−205564号公報、特開平
1−35369号公報に開示されているものを使用する
ことができる。尚、特開昭60−47696号公報に記
載の耐拡散性カプラーを使用することが好ましい。カプ
ラーの含有量は、カプラーの種類によって異なるが、約
1〜5g/m2 が好ましい。The coupler as a dye precursor used in the present invention is disclosed in Japanese Patent Application Laid-open No. 57-94653 and Japanese Patent Application Laid-open No. 57-94653.
-94654 publication, JP-A-57-94655 publication,
JP-A-60-47696, JP-A-63-1271
Those disclosed in Japanese Patent Application Laid-open No. 58, Japanese Patent Application Laid-Open No. 63-205564, and Japanese Patent Application Laid-open No. 1-35369 can be used. Incidentally, it is preferable to use a diffusion-resistant coupler described in JP-A-60-47696. The content of coupler varies depending on the type of coupler, but is preferably about 1 to 5 g/m2.
【0013】カプラーを試薬層に含有させる場合は、有
機溶媒に溶解した後、塗布液に添加することができる。
カプラー、特に耐拡散性のカプラーを試薬層中にも含有
させる場合、写真技術に用いられるオイルプロテクト法
で添加することが好ましい。具体的には、耐拡散性カプ
ラーを高沸点溶媒と共に有機溶媒に溶解し、アニオン系
界面活性剤及び/又は非イオン系界面活性剤を含むゼラ
チン等の親水性コロイドを含む水溶液と混合し、高速回
転ミキサ、コロイドミル又は超音波分散装置等で乳化分
散すればよい。この時、用いられる高沸点溶媒としては
フタル酸ジブチル等が好ましく用いられ、その量は試薬
層固形分に対して2〜8重量%が好ましい。When the coupler is contained in the reagent layer, it can be added to the coating solution after being dissolved in an organic solvent. When a coupler, particularly a diffusion-resistant coupler, is also included in the reagent layer, it is preferable to add it by an oil protection method used in photographic technology. Specifically, a diffusion-resistant coupler is dissolved in an organic solvent together with a high-boiling point solvent, mixed with an aqueous solution containing a hydrophilic colloid such as gelatin containing an anionic surfactant and/or a nonionic surfactant, and a high-speed Emulsification and dispersion may be performed using a rotary mixer, a colloid mill, an ultrasonic dispersion device, or the like. At this time, dibutyl phthalate or the like is preferably used as the high boiling point solvent, and the amount thereof is preferably 2 to 8% by weight based on the solid content of the reagent layer.
【0014】本発明においては、ザルコシンオキシダー
ゼ等の酵素及び7−クロロ−3−(2−ヘキシルデシル
スルホニルエチル)−6−メチル−ピラゾロ−〔3,2
−c〕−s−トリアゾール等のカプラーが試薬層に含有
される訳であるが、例えば牛血清アルブミン等のタンパ
ク質が試薬層固形分の約10重量%以上、好ましくは1
5重量%以上含まれる。牛血清アルブミン等のタンパク
質を試薬層に含有せしめるには、試薬層固形分の約10
重量%以上となるように配合された牛血清アルブミン等
のタンパク質含有溶液中にザルコシンオキシダーゼ等の
酵素を溶解させ、この溶液を上記カプラー含有親水性コ
ロイド水溶液に添加混合し、これを支持体上に塗布すれ
ば良い。In the present invention, enzymes such as sarcosine oxidase and 7-chloro-3-(2-hexyldecylsulfonylethyl)-6-methyl-pyrazolo-[3,2
A coupler such as -c]-s-triazole is contained in the reagent layer.
Contains 5% by weight or more. In order to contain proteins such as bovine serum albumin in the reagent layer, the solid content of the reagent layer should be approximately 10
An enzyme such as sarcosine oxidase is dissolved in a solution containing protein such as bovine serum albumin in a concentration of % by weight or more, this solution is added to and mixed with the coupler-containing hydrophilic colloid aqueous solution, and this is applied onto a support. It should be applied to.
【0015】そして、このようにして塗設された試薬層
は、塗布に際してはじき等の塗布ムラが起きにくいもの
であり、塗膜の厚みにバラツキが少なく、さらにはザル
コシンオキシダーゼの酵素活性の低下が起きにくいもの
であり、高感度で、かつ、バラツキの少ない分析素子が
得られる。しかも、バラツキが少ないものであるから、
製造ロットを大きく出来、従って製造コストが低廉とな
り、かつ、バラツキも少なくなる。[0015] The reagent layer coated in this manner is less likely to cause uneven coating such as repelling during coating, has less variation in the thickness of the coated film, and is furthermore free from a decrease in the enzyme activity of sarcosine oxidase. It is difficult for this to occur, and an analytical element with high sensitivity and little variation can be obtained. Moreover, since there is little variation,
The production lot can be made larger, and therefore the production cost can be lowered and variations can also be reduced.
【0016】本発明の分析素子は、製造上又は操作上の
有利性の為に、一般の分析素子に用いられる一種又は二
種以上の他の添加物を含有することができる。このよう
な添加物には、界面活性剤、イオンキレート化剤、緩衝
剤、溶剤、硬化剤、抗酸化剤、及び類似物が含まれる。
界面活性剤は非イオン性、イオン性を問わずに用いられ
るが、非イオン性界面活性剤は、有機溶媒にも水にも良
く溶解することから有用な塗布助剤であると共に、生物
学的流体試料を多孔性展開層上に垂らした際の展開速度
の向上に有効であるから、特に好ましいものである。界
面活性剤として有用な具体例としては、トリトンX−1
00(オクチルフェノキシポリエトキシエタノール、ロ
ームアンドハース社製)、サーファクタント10G(p
−ノニルフェノキシポリグリシドール、オリーン社製)
、アルカノールXC(ジイソプロピルナフチルスルホン
酸ナトリウム、デュポン社製)、トリイソプロピルナフ
タレンスルホン酸ナトリウム、フルオロテンサイドFT
−248(パーフルオロオクチルスルホン酸テトラエチ
ルアンモニウム塩、バイエル社製)、フロラードFC−
170C(パーフルオロアルキルポリオキシエチレンエ
タノール、3M社製)等の非イオン性及びイオン性界面
活性剤を挙げることができる。特に、多孔性展開層に含
まれる界面活性剤としては非イオン系界面活性剤が好ま
しく、次の
R−O−(CH2 −CH2 −O−)n H(式中R
は炭素数1〜9のアルキル基で置換されたフェニル基又
は炭素数1〜20のアルキル基を示し、nは1〜70の
整数を示す)で表される非イオン系界面活性剤を5〜2
0g/m2 含んでいるものが好ましい。The analytical element of the present invention may contain one or more other additives used in general analytical elements for manufacturing or operational advantages. Such additives include surfactants, ion chelators, buffers, solvents, hardeners, antioxidants, and the like. Surfactants can be used regardless of whether they are nonionic or ionic. Nonionic surfactants are useful coating aids because they dissolve well in both organic solvents and water, and they also have biological properties. This is particularly preferred since it is effective in improving the development speed when a fluid sample is dropped onto the porous development layer. Specific examples useful as surfactants include Triton X-1
00 (octylphenoxypolyethoxyethanol, manufactured by Rohm and Haas), surfactant 10G (p
-nonylphenoxy polyglycidol, manufactured by Orin)
, Alkanol
-248 (perfluorooctyl sulfonic acid tetraethylammonium salt, manufactured by Bayer AG), Florado FC-
Mention may be made of nonionic and ionic surfactants such as 170C (perfluoroalkylpolyoxyethylene ethanol, manufactured by 3M). In particular, the surfactant contained in the porous spreading layer is preferably a nonionic surfactant, and the following R-O-(CH2-CH2-O-)n H (in the formula R
represents a phenyl group substituted with an alkyl group having 1 to 9 carbon atoms or an alkyl group having 1 to 20 carbon atoms, and n is an integer of 1 to 70). 2
Preferably, it contains 0g/m2.
【0017】緩衝剤としては、日本化学会編「化学便覧
基礎編」(東京、丸善株式会社、1966年発行)
1312〜1320頁、R.M.C.Dawsonほか
編「Data for Biochemical
Research」第2版(オックスフォード ア
ット ザ クレンドン プレス、1969年発行
)第476〜508頁、「Biochemistry」
第5巻、第467頁(1966年)、「Analyti
cal Biochemistry」第104巻、第
300〜310頁(1980年)等に記載のpH緩衝剤
がある。[0017] As a buffering agent, please refer to "Chemical Handbook Basic Edition" edited by the Chemical Society of Japan (Tokyo, Maruzen Co., Ltd., published in 1966).
pp. 1312-1320, R. M. C. “Data for Biochemical” edited by Dawson et al.
Research” 2nd edition (Oxford at the Clendon Press, 1969) pp. 476-508, “Biochemistry”
Volume 5, page 467 (1966), “Analyti
104, pages 300-310 (1980).
【0018】pH5.5〜9.0の範囲のpH緩衝剤の
具体例として、トリス(ヒドロキシメチル)アミノメタ
ン〔トリス(Tris)〕を含む緩衝剤、リン酸塩を含
む緩衝剤、ホウ酸塩を含む緩衝剤、クエン酸又はクエン
酸塩を含む緩衝剤、グリシンを含む緩衝剤、N,N−ビ
ス(2−ヒドロキシエチル)グリシン〔ビシン(Bic
ine)〕、N−2−ヒドロキシエチルピペラジン−N
’−2−ヒドロキシプロパン−3−スルホン酸(HEP
PS)Na塩又はK塩等、N−2−ヒドロキシエチルピ
ペラジン−N’−3−スルホン酸(EPPS)Na塩又
はK塩等、N−〔トリス(ヒドロキシメチル)メチル〕
−3−アミノプロパンスルホン酸(TAPS)Na塩又
はK塩等、N−2−ヒドロキシエチルピペラジン−N’
−2−エタンスルホン酸(HEPES)Na塩又はK塩
等、N−トリス(ヒドロキシメチル)メチル−2−アミ
ノエタンスルホン酸(TES)Na塩又はK塩等、及び
これらのいずれかと必要により組み合わせられる酸、ア
ルカリ又は塩がある。好ましい緩衝剤の具体例として、
リン酸二水素カリウム−リン酸水素二ナトリウム、トリ
ス−ホウ酸ナトリウム、トリスクエン酸、クエン酸−リ
ン酸二水素ナトリウム、ビシン、HEPPS、HEPP
Sナトリウム塩、HEPESカリウム塩、EPPS、E
PPSナトリウム塩、TAPS、TAPSナトリウム塩
、TES、TESナトリウム塩、TESカリウム塩等が
ある。Specific examples of pH buffers in the range of pH 5.5 to 9.0 include buffers containing tris(hydroxymethyl)aminomethane (Tris), buffers containing phosphate, and borate. Buffers containing citric acid or citrate, buffers containing glycine, N,N-bis(2-hydroxyethyl)glycine [Bicine (Bic
ine)], N-2-hydroxyethylpiperazine-N
'-2-Hydroxypropane-3-sulfonic acid (HEP
PS) Na salt or K salt, etc., N-2-hydroxyethylpiperazine-N'-3-sulfonic acid (EPPS) Na salt or K salt, etc., N-[tris(hydroxymethyl)methyl]
-3-aminopropanesulfonic acid (TAPS) Na salt or K salt, etc., N-2-hydroxyethylpiperazine-N'
-2-ethanesulfonic acid (HEPES) Na salt or K salt, etc., N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES) Na salt or K salt, etc., and can be combined with any of these if necessary There are acids, alkalis or salts. Specific examples of preferred buffers include:
Potassium dihydrogen phosphate-disodium hydrogen phosphate, tris-sodium borate, triscitric acid, citric acid-sodium dihydrogen phosphate, bicine, HEPPS, HEPP
S sodium salt, HEPES potassium salt, EPPS, E
Examples include PPS sodium salt, TAPS, TAPS sodium salt, TES, TES sodium salt, TES potassium salt, and the like.
【0019】pH緩衝剤は酵素が含有されている層に存
在するのが好ましいので、酵素を含有する多孔性展開層
又は試薬層にpH緩衝剤を含有させるのが好ましい。低
分子量のpH緩衝剤は、垂らされた水性液体試料の媒体
である水の浸透に従って層間を移動しうるので、酵素と
発色試薬組成物が含まれる全ての層にpH緩衝剤が含有
される必要はなく、例えば親水性層又は吸水層だけにp
H緩衝剤を含有させてもよい。Since the pH buffer is preferably present in the enzyme-containing layer, the pH buffer is preferably contained in the enzyme-containing porous development layer or reagent layer. Since low molecular weight pH buffers can migrate between layers as water permeates, which is the medium of the applied aqueous liquid sample, pH buffers need to be included in all layers containing the enzyme and coloring reagent compositions. For example, p is only present in the hydrophilic or water absorbing layer.
H buffering agent may be included.
【0020】試薬層においてオイルプロテクト法でカプ
ラーを分散する際に添加される高沸点溶媒としてはフタ
ル酸ジブチル等が好ましく用いられ、その量は1〜4g
/m2 が好ましい。本発明の実施においてクレアチナ
ーゼやザルコシンオキシダーゼを多孔性展開層に含有さ
せることは多くの方法により達成できる。例えば、多孔
性展開層を形成する方法として塗布を用いる場合は、塗
布液の溶媒に溶解する(溶媒が水の場合等)ことが一般
的である。溶媒に対する試薬の溶解度が適当でない場合
は、不溶のまま溶媒中に分散させても良い。分散に関す
る種々の方法については、新実験化学講座、第18巻、
「界面とコロイド」(丸善株式会社、日本化学会編、昭
和52年発行)第340〜355頁に記載されている方
法を用いることができる。又、溶媒を用いるか否かに係
わらず、前記の多孔性展開層構成材料にあらかじめクレ
アチナーゼやザルコシンオキシダーゼを物理的、化学的
に吸着させるか、あるいは多孔性展開層構成材料の一部
として単に混合しておいても良い。好ましくは、ベンゼ
ン、トルエン、キシレン、エーテル、ヘキサン及びその
誘導体等の常温で液体である有機溶媒に非イオン系界面
活性剤、多孔性展開層構成素材及びクレアチナーゼやザ
ルコシンオキシダーゼを添加し、サンドスターラー、ホ
モジナイザー、超音波ホモジナイザー等により分散させ
、分散液を塗布乾燥し、多孔性展開層を形成する方法が
良い。Dibutyl phthalate or the like is preferably used as the high boiling point solvent added when dispersing the coupler in the oil protection method in the reagent layer, and the amount thereof is 1 to 4 g.
/m2 is preferred. Incorporation of creatinase or sarcosine oxidase into the porous spreading layer in the practice of the present invention can be accomplished in many ways. For example, when coating is used as a method for forming a porous development layer, it is common to dissolve it in a solvent of a coating liquid (for example, when the solvent is water). If the solubility of the reagent in the solvent is not appropriate, it may be dispersed in the solvent without being dissolved. For various methods regarding dispersion, see New Experimental Chemistry Course, Volume 18,
The method described in "Interfaces and Colloids" (Maruzen Co., Ltd., edited by the Chemical Society of Japan, published in 1976), pages 340 to 355, can be used. In addition, regardless of whether a solvent is used or not, creatinase or sarcosine oxidase can be physically or chemically adsorbed onto the porous developing layer constituent material in advance, or simply as part of the porous developing layer constituent material. You can also mix them. Preferably, a nonionic surfactant, a porous developing layer constituent material, and creatinase or sarcosine oxidase are added to an organic solvent that is liquid at room temperature, such as benzene, toluene, xylene, ether, hexane, and its derivatives, and the mixture is stirred using a sand stirrer. , a homogenizer, an ultrasonic homogenizer, etc., and then applying and drying the dispersion liquid to form a porous spread layer.
【0021】本発明になる乾式の分析素子の多孔性展開
層は、自己支持性(すなわち、その元の形を維持するに
十分に硬い物質からなる)であるが、好ましくはそれは
別の非孔性支持体の上に置かれている。このような支持
体は適当な寸法安定性が有り、好ましくは、非孔性で、
200ないし900nmの間の波長の電磁放射線を透過
し得る透明(すなわち放射線透過性)物質である。特定
の分析素子の為の支持体の選択は、検出しようとする態
様(透過又は反射分光測光)に適合させるべきである。
有用な支持体は、紙、金属箔、ポリスチレン、ポリエス
テル(例えば、ポリエチレンテレフタレート)、ポリカ
ーボネート又はセルロースエステル(例えば、セルロー
スアセテート)等である。Although the porous spreading layer of the dry analytical element of the present invention is self-supporting (ie, composed of a material sufficiently rigid to maintain its original shape), it is preferably formed of another non-porous material. placed on a sexual support. Such supports have adequate dimensional stability, are preferably non-porous, and
It is a transparent (ie, radiation-transparent) material that is capable of transmitting electromagnetic radiation of wavelengths between 200 and 900 nm. The choice of support for a particular analytical element should be adapted to the mode of detection (transmission or reflection spectrophotometry) to be detected. Useful supports include paper, metal foil, polystyrene, polyester (eg polyethylene terephthalate), polycarbonate or cellulose ester (eg cellulose acetate), and the like.
【0022】本発明における多孔性展開層は、米国特許
第4292272号明細書、米国特許第3992158
号明細書、米国特許第4258001号明細書、米国特
許第4430436号明細書及び特開昭57−1017
60号公報に記載されたような繊維若しくは非繊維性物
質、又はそれら両者の混合物や特公昭61−61347
号公報に記載されたような織物から調製される。The porous spreading layer in the present invention is described in US Pat. No. 4,292,272 and US Pat. No. 3,992,158.
specification, U.S. Patent No. 4,258,001, U.S. Patent No. 4,430,436, and JP-A-57-1017
Fibers or non-fibrous substances as described in Japanese Patent Publication No. 61-61347, or a mixture of both.
It is prepared from a fabric such as that described in the publication.
【0023】本発明の分析素子には、所望に応じて種々
の機能の層及び層構成をとることができる。例えば、米
国特許第3992158号明細書記載の試薬層、反射層
、下塗り層、米国特許第4042335号明細書記載の
放射線ブロッキング層、米国特許第4066403号明
細書記載のバリヤー層、米国特許第4144306号明
細書記載のレジストレーション層、米国特許第4166
093号明細書記載のマイグレーション阻止層、米国特
許第4127499号明細書記載のシンチレーション層
、特開昭55−90859号公報記載のスカベンジャー
層及び米国特許第4110079号明細書記載の破壊性
ポッド状部材等を任意に組み合わせて本発明の目的に合
わせた多層分析素子を構成するこが可能である。The analytical element of the present invention can have various functional layers and layer configurations as desired. For example, reagent layers, reflective layers, subbing layers as described in US Pat. No. 3,992,158, radiation blocking layers as described in US Pat. No. 4,042,335, barrier layers as described in US Pat. No. 4,066,403, US Pat. No. 4,144,306. Registration layer as described in US Pat. No. 4,166
The migration prevention layer described in No. 093, the scintillation layer described in U.S. Pat. No. 4,127,499, the scavenger layer described in JP-A-55-90859, the breakable pod-shaped member described in U.S. Pat. No. 4,110,079, etc. It is possible to construct a multilayer analytical element that meets the purpose of the present invention by combining them arbitrarily.
【0024】上記の種々の層は、写真工業において公知
のスライドホッパー塗布法、押し出し塗布法、浸漬塗布
法等を用いることで任意の膜厚の層を構成することが可
能である。又、層構成としては、例えば特開昭51−4
0191号(特公昭58−18628号)公報、米国特
許第4110079号明細書、特開昭58−13156
5号公報等に記載されている層構成を選択することが可
能である。The various layers mentioned above can be formed into layers of arbitrary thickness by using slide hopper coating, extrusion coating, dip coating, etc., which are known in the photographic industry. In addition, as for the layer structure, for example, JP-A-51-4
0191 (Japanese Patent Publication No. 58-18628), U.S. Patent No. 4110079, JP-A-58-13156
It is possible to select the layer structure described in Publication No. 5 and the like.
【0025】このようにして製造された分析素子は、分
析方法に依存して種々の形状にすることが可能である。
例えば、所望の幅のテープ、シート又はプラスチックマ
ウントに装着されたスライドを含む種々の形状にするこ
とができる。以下、本発明を具体的に説明するが、本発
明はこの実施例に限定されない。The analytical element manufactured in this way can be made into various shapes depending on the analytical method. For example, it can be of various shapes including tape, sheet or slides mounted on plastic mounts of the desired width. The present invention will be specifically explained below, but the present invention is not limited to this example.
【0026】[0026]
【実施例】透明な下塗り済み厚さ約180μmのポリエ
チレンテレフタレート支持体上に、下記の表1に示す試
薬層を設けた。
表
1(試薬層) R−1
R−2 R−3
R−4A 20
同 左
同 左 同 左B
0.9 同 左
同 左 同 左
C 1.8 同
左 同 左
同 左D 3.0
同 左 同 左
同 左E
0.09 同 左 同
左 同 左 F
30000(0.14g) 同 左
同 左 同
左G 14000(0.50g) 同
左 同 左
同 左H 6500(0.23g)
同 左 同 左
同 左I 1500(0.
14g) 同 左 同
左 同 左J
6.2 同 左
同 左 同 左K
1.5 同 左
同 左 同
左L 6.2
3.9 1.0
−尚、表1中、Aはゼラチン(g/m2 )
、Bはトリイソプロピルナフタレンスルホン酸ナトリウ
ム(g/m2 )、Cはフタル酸ジブチル(g/m2
)、Dは7−クロロ−3−(2−ヘキシルデシルスルホ
ニルエチル)−6−メチル−ピラゾロ−〔3 ,2−c
〕−s−トリアゾール(g/m2 )、Eは1,2−ビ
ス(ビニルスルホニル)エタン(g/m2 )、Fはペ
ルオキシダーゼ(I.U./m2 、比活性209.3
U/mg)、Gはザルコシンオキシダーゼ(I.U./
m2 、比活性28.1U/mg)、Hはクレアチニナ
ーゼ(I.U./m2 、比活性278U/mg)、I
はクレアチナーゼ(I.U./m2 、比活性10.8
U/mg)、JはN−2−ヒドロキシエチルピペラジン
−N’−2−エタンスルホン酸緩衝剤(g/m2 )、
Kは水酸化カリウム(g/m2 )、Lは牛血清アルブ
ミン(g/m2 )である。又、表1において、試薬層
R−1における牛血清アルブミンの含有量は約20重量
%、試薬層R−2における牛血清アルブミンの含有量は
約10重量%、試薬層R−3における牛血清アルブミン
の含有量は約3重量%である。この試薬層は、写真技術
の分野で用いられているオイルプロテクト法を用いて、
先ず7−クロロ−3−(2−ヘキシルデシルスルホニル
エチル)−6−メチル−ピラゾロ−〔3 ,2−c〕−
s−トリアゾールとフタル酸ジブチルを適当量の酢酸エ
チルに溶解し、この溶液をトリイソプロピルナフタレン
スルホン酸ナトリウム(界面活性剤)を含有するゼラチ
ン水溶液と混合し、高速回転ミキサ及び超音波分散装置
で乳化分散し、この乳化分散溶液に1,2−ビス(ビニ
ルスルホニル)エタン、N−2−ヒドロキシエチルピペ
ラジン−N’−2−エタンスルホン酸緩衝剤を添加混合
し、他方、ペルオキシダーゼ、ザルコシンオキシダーゼ
、クレアチニナーゼ及びクレアチナーゼを、約10℃の
牛血清アルブミン水溶液(KOHでpH8.0に調整)
に溶解させた後、これを前記のカプラー含有溶液に添加
し、この試薬層溶液をポリエチレンテレフタレート支持
体上に塗布して構成されたものである。この試薬層の構
成に際して、酵素添加後15分後に塗布したもの(R−
1a,R−2a,R−3a,R−4a)と、酵素添加後
45分後に塗布したもの(R−1b,R−2b,R−3
b,R−4b)とを作成した。尚、牛血清アルブミンを
用いない場合には、牛血清アルブミン水溶液の代わりに
蒸留水を用いた。EXAMPLE A reagent layer shown in Table 1 below was provided on a transparent undercoated polyethylene terephthalate support having a thickness of about 180 μm. Table 1 (Reagent layer) R-1
R-2 R-3
R-4A 20
Same left
Same left Same left B
0.9 Same left
Same left Same left C 1.8 Same left Same left
Same left D 3.0
Same left Same left
Same left E
0.09 Same left Same left Same left F
30000 (0.14g) Same as left
Same left Same
Left G 14000 (0.50g) Same left Same left
Same left H 6500 (0.23g)
Same left Same left
Same left I 1500 (0.
14g) Same as left Same as left
Left Same left J
6.2 Same as left
Same left Same left K
1.5 Same left Same left Same left L 6.2
3.9 1.0
- In Table 1, A is gelatin (g/m2)
, B is sodium triisopropylnaphthalene sulfonate (g/m2), C is dibutyl phthalate (g/m2)
), D is 7-chloro-3-(2-hexyldecylsulfonylethyl)-6-methyl-pyrazolo-[3,2-c
]-s-triazole (g/m2), E is 1,2-bis(vinylsulfonyl)ethane (g/m2), F is peroxidase (I.U./m2, specific activity 209.3)
U/mg), G is sarcosine oxidase (I.U./mg), G is sarcosine oxidase (I.U./mg),
m2, specific activity 28.1 U/mg), H is creatininase (I.U./m2, specific activity 278 U/mg), I
is creatinase (I.U./m2, specific activity 10.8
U/mg), J is N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid buffer (g/m2),
K is potassium hydroxide (g/m2), and L is bovine serum albumin (g/m2). Further, in Table 1, the content of bovine serum albumin in reagent layer R-1 is approximately 20% by weight, the content of bovine serum albumin in reagent layer R-2 is approximately 10% by weight, and the content of bovine serum albumin in reagent layer R-3 is approximately 20% by weight. The albumin content is approximately 3% by weight. This reagent layer is created using the oil protection method used in the field of photography.
First, 7-chloro-3-(2-hexyldecylsulfonylethyl)-6-methyl-pyrazolo-[3,2-c]-
Dissolve s-triazole and dibutyl phthalate in an appropriate amount of ethyl acetate, mix this solution with an aqueous gelatin solution containing sodium triisopropylnaphthalene sulfonate (surfactant), and emulsify using a high-speed rotating mixer and an ultrasonic dispersion device. 1,2-bis(vinylsulfonyl)ethane and N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid buffer were added and mixed to this emulsified dispersion solution, and on the other hand, peroxidase, sarcosine oxidase, Creatininase and creatinase were added to an aqueous solution of bovine serum albumin at approximately 10°C (adjusted to pH 8.0 with KOH).
After dissolving this in the coupler-containing solution, this was added to the coupler-containing solution, and this reagent layer solution was coated on a polyethylene terephthalate support. When constructing this reagent layer, the one applied 15 minutes after the addition of the enzyme (R-
1a, R-2a, R-3a, R-4a) and those applied 45 minutes after enzyme addition (R-1b, R-2b, R-3
b, R-4b) were created. Note that when bovine serum albumin was not used, distilled water was used instead of the bovine serum albumin aqueous solution.
【0027】次いで、この試薬層上にビニルピロリドン
−酢酸ビニル共重合体(重合比2:8)を1.8g/m
2 となるように設けて接着層を構成し、さらにこの接
着層上に下記のようにして多孔性展開層を塗設した。す
なわち、11.8g/m2 となるようなトリトンX−
100及び11.0g/m2 となるようなスチレン−
グリシジルメタクリレート共重合体(重合比9:1)を
キシレン280gに溶解した後、106g/m2 とな
るような濾紙原材料用繊維、0.2g/m2 となるよ
うな塩酸4−N,N−ジエチルアミノ−2−(2’−メ
タンスルホンアミドエチル) アニリン、1.7g/m
2 となるような5,5−ジメチル−1,3−シクロヘ
キサンジオンを添加、攪拌し、次いで12000I.U
./m2 となるようなアスコルビン酸オキシダーゼ、
112500I.U./m2 となるようなクレアチナ
ーゼ及び2.0g/m2 となるような牛血清アルブミ
ンの混合物を添加し、ホモジナイザーで分散して出来上
がった分散液を接着層の上から塗布、乾燥して多孔性展
開層を構成した。Next, 1.8 g/m of vinylpyrrolidone-vinyl acetate copolymer (polymerization ratio 2:8) was applied onto this reagent layer.
2 to form an adhesive layer, and a porous spreading layer was further coated on this adhesive layer in the following manner. That is, Triton X-
100 and 11.0 g/m2 of styrene.
After dissolving glycidyl methacrylate copolymer (polymerization ratio 9:1) in 280 g of xylene, fiber for filter paper raw material was added to give a weight of 106 g/m2, and 4-N,N-diethylamino-hydrochloric acid was added to give a weight of 0.2 g/m2. 2-(2'-methanesulfonamidoethyl) aniline, 1.7g/m
2 of 5,5-dimethyl-1,3-cyclohexanedione was added and stirred, and then 12,000 I. U
.. /m2 ascorbic acid oxidase,
112500I. U. /m2 of creatinase and bovine serum albumin of 2.0g/m2 are added, dispersed with a homogenizer, the resulting dispersion is applied over the adhesive layer, and dried to form a porous spreadable layer. was constructed.
【0028】このようにして構成された分析素子の構成
は表2に示す通りである。
上記各例の分析素子に対して、コントロール血清N「ロ
シュ」(エフ・ホフマン・ラ・ロシュ社製)を10μl
滴下し、37℃でインキュベートし、546nmにおけ
る3分30秒と7分の反射濃度差を求めたので、その結
果を表3に示す。The structure of the analytical element thus constructed is shown in Table 2. For the analytical elements in each of the above examples, add 10 μl of control serum N "Roche" (manufactured by F. Hoffmann-La Roche).
The solution was added dropwise and incubated at 37° C., and the difference in reflection density at 546 nm between 3 minutes and 30 seconds and 7 minutes was determined. The results are shown in Table 3.
【0029】
これによれば、ザルコシンオキシダーゼ添加から塗布ま
でに要する時間が掛かっても、本発明になるものでは悪
影響が殆どないのに対して、比較例になるものではザル
コシンオキシダーゼ添加から塗布までに要する時間が長
くなると感度の低下が起きている。According to this, even if it takes a long time from the addition of sarcosine oxidase to the application, the product of the present invention has almost no adverse effect, whereas the product of the comparative example has a long time from the addition of sarcosine oxidase to the application. As the time required for this process increases, sensitivity decreases.
【0030】又、本発明の分析素子−1,−3及び比較
例の分析素子−1,−3を40℃下に3日間保存し、強
制劣化させた後、コントロール血清N「ロシュ」を10
μl滴下し、37℃でインキュベートし、3分30秒と
7分の546nmにおける反射濃度差を求めたので、そ
の結果を表4に示す。
表
4
反射濃度差
強制劣化前 強制劣化後
本発明の分析素子−1 0
.0309 0.0297
本発明の分析素子−3 0.0291 0
.0272 比較例の分析素子−1
0.0256 0.0204
比較例の分析素子−3 0.0224
0.0148これによれば、本発明になる分析
素子は安定した特性を示しており、保存性に優れている
ことが判る。In addition, the analytical elements-1 and -3 of the present invention and the analytical elements-1 and -3 of the comparative example were stored at 40°C for 3 days for forced deterioration, and then control serum N "Roche" was added at 10°C.
μl was added dropwise, incubated at 37° C., and the difference in reflection density at 546 nm between 3 minutes and 30 seconds and 7 minutes was determined. The results are shown in Table 4. Table 4
Reflection density difference
Before forced degradation After forced degradation Analytical element of the present invention-1 0
.. 0309 0.0297
Analytical element of the present invention-3 0.0291 0
.. 0272 Analytical element-1 of comparative example
0.0256 0.0204
Analytical element-3 of comparative example 0.0224
0.0148 According to this, it can be seen that the analytical element of the present invention exhibits stable characteristics and has excellent storage stability.
【0031】又、本発明の分析素子−1,−3及び比較
例の分析素子−1,−3に対してコントロール血清N「
ロシュ」を10μl滴下し、37℃でインキュベートし
、3分30秒と7分の546nmにおける反射濃度差を
求め、そして予め種々のクレアチニンを含む人血清を用
いて作成しておいた変換式で濃度値に変換した。これを
各素子についてN=18で行い、同時再現性を調べたの
で、その結果を表5に示す。[0031] In addition, control serum N'
10 μl of ``Roche'' was added dropwise, incubated at 37°C, the difference in reflection density at 546 nm for 3 minutes and 30 seconds and 7 minutes was determined, and the concentration was determined using a conversion formula prepared in advance using human serum containing various creatinine. converted to a value. This was performed for each element with N=18 to examine simultaneous reproducibility, and the results are shown in Table 5.
【0032】
この表5から、本発明になる分析素子は同時再現性に優
れたものであることが窺える。From Table 5, it can be seen that the analytical element of the present invention has excellent simultaneous reproducibility.
【0033】[0033]
【効果】本発明の分析素子は、感度並びに同時再現性に
優れ、しかも保存性が良いものである。[Effects] The analytical element of the present invention has excellent sensitivity and simultaneous reproducibility, and has good storage stability.
Claims (2)
る試薬層を有する生物学的流体試料中の特定成分を分析
する為の分析素子であって、前記試薬層に該試薬層固形
分の約10重量%以上のタンパク質を含有させたことを
特徴とする分析素子。1. An analytical element for analyzing a specific component in a biological fluid sample, comprising a reagent layer containing a coupler and an enzyme on a support, the reagent layer having a solid content of about An analytical element characterized by containing 10% by weight or more of protein.
る試薬層を有する生物学的流体試料中の特定成分を分析
する為の分析素子の製造方法であって、該試薬層固形分
の約10重量%以上となるように配合されたタンパク質
含有溶液中に前記酵素が添加されて作成されたカプラー
、酵素及びタンパク質含有溶液が前記支持体上に塗布さ
れることを特徴とする分析素子の製造方法。2. A method for producing an analytical element for analyzing a specific component in a biological fluid sample having a reagent layer containing a coupler and an enzyme on a support, the reagent layer having a solid content of about 10 A method for manufacturing an analytical element, characterized in that the coupler prepared by adding the enzyme to a protein-containing solution blended at a weight % or more, and the enzyme- and protein-containing solution are coated on the support. .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8272891A JPH04316497A (en) | 1991-04-15 | 1991-04-15 | Analytical element and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8272891A JPH04316497A (en) | 1991-04-15 | 1991-04-15 | Analytical element and its production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04316497A true JPH04316497A (en) | 1992-11-06 |
Family
ID=13782484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8272891A Pending JPH04316497A (en) | 1991-04-15 | 1991-04-15 | Analytical element and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04316497A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012235771A (en) * | 2011-04-28 | 2012-12-06 | Arkray Inc | Dry test strip and method for measuring creatinine |
CN109187403A (en) * | 2018-10-19 | 2019-01-11 | 海南师范大学 | A kind of differential protein detection method of 5- phenyl -1- (p-methylphenyl) -1H- triazole and serum effect |
-
1991
- 1991-04-15 JP JP8272891A patent/JPH04316497A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012235771A (en) * | 2011-04-28 | 2012-12-06 | Arkray Inc | Dry test strip and method for measuring creatinine |
CN109187403A (en) * | 2018-10-19 | 2019-01-11 | 海南师范大学 | A kind of differential protein detection method of 5- phenyl -1- (p-methylphenyl) -1H- triazole and serum effect |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4828983A (en) | Use of phenols and anilines to increase the rate of peroxidase catalyzed oxidation of leuco dyes | |
US4153668A (en) | Multi-zone analytical element and method using same | |
EP0653637B1 (en) | Dry elements, test devices, test kits and methods for chemiluminescent detection of analytes using peroxidase labeled reagents | |
US5155024A (en) | Binder composition and analytical element having stabilized peroxidase in layer containing the composition | |
US4732736A (en) | Analytical element for the detection hydrogen peroxide | |
US4874692A (en) | Binder composition and analytical element having stabilized peroxidase in layer containing the composition | |
US4567024A (en) | Analytical element | |
US4956146A (en) | Dry analytical element and process for producing the same | |
US5372932A (en) | Analytical element and method for the determination of a specific binding ligand using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer | |
EP0699908B1 (en) | Immunoassay elements having stable leuco dye coatings | |
JPH04316497A (en) | Analytical element and its production | |
JPH029310B2 (en) | ||
DE69530148T2 (en) | Analytical element, composition and method using modified apo-horseradish peroxidase | |
US4914020A (en) | Multi-layer analytical element with preserved enzyme containing spreading layer | |
JP5285000B2 (en) | Method for measuring low density lipoprotein cholesterol | |
CA2157202C (en) | Leuco dye coating compositions | |
JPH04311399A (en) | Analytic element | |
JPH02283298A (en) | Analyzing element | |
JPS62115368A (en) | Integral type multi-layer analyzing element for analyzing cholesterol | |
JPH0518959A (en) | Analytical element | |
JPS63158000A (en) | Integrated multi-layer analytic element for quantitative determination of total cholesterol | |
JPS5944658A (en) | Analytical element | |
JPH0523199A (en) | Analytical element and analyzing method | |
JPS63231264A (en) | Dry type analysis element | |
JPS5991896A (en) | Multilayered analytical element for measuring reduced form coenzyme |